These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Kudo H, Yata Y, Takahara T, Kawai K, Nakayama Y, Kanayama M, Oya T, Morita S, Sasahara M, Mann DA, Sugiyama T. Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026 [Abstract] [Full Text] [Related]
4. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis. Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K. J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963 [Abstract] [Full Text] [Related]
5. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. Mas E, Danjoux M, Garcia V, Carpentier S, Ségui B, Levade T. Dig Liver Dis; 2013 Feb; 45(2):147-54. PubMed ID: 23044079 [Abstract] [Full Text] [Related]
6. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174 [Abstract] [Full Text] [Related]
7. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses. Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E. Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906 [Abstract] [Full Text] [Related]
8. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Tomita K, Tamiya G, Ando S, Ohsumi K, Chiyo T, Mizutani A, Kitamura N, Toda K, Kaneko T, Horie Y, Han JY, Kato S, Shimoda M, Oike Y, Tomizawa M, Makino S, Ohkura T, Saito H, Kumagai N, Nagata H, Ishii H, Hibi T. Gut; 2006 Mar; 55(3):415-24. PubMed ID: 16174657 [Abstract] [Full Text] [Related]
9. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis. Uno M, Kurita S, Misu H, Ando H, Ota T, Matsuzawa-Nagata N, Kita Y, Nabemoto S, Akahori H, Zen Y, Nakanuma Y, Kaneko S, Takamura T. Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789 [Abstract] [Full Text] [Related]
11. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice. Nan YM, Han F, Kong LB, Zhao SX, Wang RQ, Wu WJ, Yu J. Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493 [Abstract] [Full Text] [Related]
12. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM. Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [Abstract] [Full Text] [Related]
13. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice. Ahsan MK, Okuyama H, Hoshino Y, Oka S, Masutani H, Yodoi J, Nakamura H. Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881 [Abstract] [Full Text] [Related]
14. Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model. Shimozono R, Nishimura K, Akiyama H, Funamoto S, Izawa A, Sai T, Kunita K, Kainoh M, Suzuki T, Kawada N. J Interferon Cytokine Res; 2015 Jun; 35(6):464-73. PubMed ID: 25715168 [Abstract] [Full Text] [Related]
15. [Mechanism of hepatocyte regeneration inhibition in rats with liver fibrosis induced by lipogenic methionine-choline- deficient diet]. Mu YP, Xi XH, Chen XR. Zhonghua Yi Xue Za Zhi; 2009 Dec 29; 89(48):3430-6. PubMed ID: 20223120 [Abstract] [Full Text] [Related]
16. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Tomita K, Teratani T, Suzuki T, Shimizu M, Sato H, Narimatsu K, Okada Y, Kurihara C, Irie R, Yokoyama H, Shimamura K, Usui S, Ebinuma H, Saito H, Watanabe C, Komoto S, Kawaguchi A, Nagao S, Sugiyama K, Hokari R, Kanai T, Miura S, Hibi T. Hepatology; 2014 Jan 29; 59(1):154-69. PubMed ID: 23832448 [Abstract] [Full Text] [Related]
17. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM. J Hepatol; 2004 Oct 29; 41(4):592-8. PubMed ID: 15464239 [Abstract] [Full Text] [Related]
18. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Ding Y, Sun X, Chen Y, Deng Y, Qian K. Eur J Pharmacol; 2015 Aug 15; 761():405-12. PubMed ID: 25967348 [Abstract] [Full Text] [Related]
19. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice. Yoshida T, Akiba J, Matsui T, Nakamura K, Hisamoto T, Abe M, Ikezono Y, Wada F, Iwamoto H, Nakamura T, Koga H, Yamagishi SI, Torimura T. Dig Dis Sci; 2017 Jun 15; 62(6):1527-1536. PubMed ID: 28365916 [Abstract] [Full Text] [Related]
20. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro. Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J, Wu CW, Tong L, Zhao J, Poon TC, Sung JJ. Int J Biochem Cell Biol; 2010 Jun 15; 42(6):948-57. PubMed ID: 20156580 [Abstract] [Full Text] [Related] Page: [Next] [New Search]